Michael Schöll, PhD

Michael Schöll, PhD

Göteborgs universitet

H-index: 54

Europe-Sweden

About Michael Schöll, PhD

Michael Schöll, PhD, With an exceptional h-index of 54 and a recent h-index of 50 (since 2020), a distinguished researcher at Göteborgs universitet, specializes in the field of Neuroscience, Neuroimaging, Dementia, Ageing.

His recent articles reflect a diverse array of research interests and contributions to the field:

Impact of simulated reduced injected dose on the assessment of amyloid PET scans

Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

Reply to Finsterer

Scenarios for the long-term efficacy of amyloid-targeting therapies in the context of the natural history of Alzheimer's disease

Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer’s Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project

CT‐based volumetric measures obtained through deep learning: Association with biomarkers of neurodegeneration

Partial volume correction in longitudinal tau PET studies-is it really needed?

Michael Schöll, PhD Information

University

Position

Wallenberg Centre for Molecular and Translational Medicine at the

Citations(all)

12304

Citations(since 2020)

10008

Cited By

5272

hIndex(all)

54

hIndex(since 2020)

50

i10Index(all)

87

i10Index(since 2020)

85

Email

University Profile Page

Göteborgs universitet

Google Scholar

View Google Scholar Profile

Michael Schöll, PhD Skills & Research Interests

Neuroscience

Neuroimaging

Dementia

Ageing

Top articles of Michael Schöll, PhD

Title

Journal

Author(s)

Publication Date

Impact of simulated reduced injected dose on the assessment of amyloid PET scans

European journal of nuclear medicine and molecular imaging

Peter Young

Fiona Heeman

Jan Axelsson

Lyduine E Collij

Anne Hitzel

...

2024/2

Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History Study

Alzheimer's & Dementia

Ariane Bollack

Lyduine E Collij

David Vállez García

Mahnaz Shekari

Daniele Altomare

...

2024/4/4

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

Nature Communications

Nicolai Franzmeier

Amir Dehsarvi

Anna Steward

Davina Biel

Anna Dewenter

...

2024/1/3

Reply to Finsterer

The Journal of Infectious Diseases

Nelly Kanberg

Michael Schöll

Arvid Edén

Magnus Gisslén

2024/3/15

Scenarios for the long-term efficacy of amyloid-targeting therapies in the context of the natural history of Alzheimer's disease

medRxiv

Lars Lau Raket

Jeffrey Cummings

Alexis Moscoso

Nicolas Villain

Michael Scholl

2024

Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer’s Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project

The Journal of Prevention of Alzheimer's Disease

K Malzbender

P Barbarino

P Barkman Ferrell

A Bradshaw

AJ Brookes

...

2024/3

CT‐based volumetric measures obtained through deep learning: Association with biomarkers of neurodegeneration

Alzheimer's & Dementia

Meera Srikrishna

Nicholas J Ashton

Alexis Moscoso

Joana B Pereira

Rolf A Heckemann

...

2024/1

Partial volume correction in longitudinal tau PET studies-is it really needed?

NeuroImage

Alejandro Costoya-Sánchez

Alexis Moscoso

Tomás Sobrino

Álvaro Ruibal

Michel J Grothe

...

2024/2/15

COVID-19 Recovery: consistent absence of cerebrospinal fluid biomarker abnormalities in patients with neurocognitive post-COVID complications

The Journal of infectious diseases

Nelly Kanberg

Anna Grahn

Erika Stentoft

Daniel Bremell

Aylin Yilmaz

...

2024/2/15

Atypical brain aging and its association with working memory performance in major depressive disorder

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging

Natalie CW Ho

Richard AI Bethlehem

Jakob Seidlitz

Nikita Nogovitsyn

Paul Metzak

...

2024/4/26

Differential Effects of Tau Stage, Lewy Body Pathology, and Substantia Nigra Degeneration on 18F-FDG PET Patterns in Clinical Alzheimer Disease

Journal of Nuclear Medicine

Jesús Silva-Rodríguez

Miguel A Labrador-Espinosa

Alexis Moscoso

Michael Schöll

Pablo Mir

...

2023/2/1

Association of chronic kidney disease with plasma NfL and other biomarkers of neurodegeneration: the H70 birth cohort study in Gothenburg

Neurology

Anna Dittrich

Nicholas J Ashton

Henrik Zetterberg

Kaj Blennow

Anna Zettergren

...

2023/7/18

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study

Alzheimer's Research & Therapy

Antoinette O’Connor

David M Cash

Teresa Poole

Pawel J Markiewicz

Maggie R Fraser

...

2023/5/25

Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology

Brain

Jesús Silva-Rodríguez

Miguel A Labrador-Espinosa

Alexis Moscoso

Michael Schöll

Pablo Mir

...

2023/11

Amyloid predicts longitudinal atrophy in non‐demented individuals: Results from the AMYPAD Prognostic & Natural History study

Alzheimer's & Dementia

Leonard Pieperhoff

Luigi Lorenzini

Sophie E Mastenbroek

Mahnaz Shekari

Alle Meije Wink

...

2023/12

User experience and biomarker associations of remotely administered and unsupervised smartphone‐based cognitive testing in a community sample of older adults

Alzheimer's & Dementia

Fredrik Öhman

Iris Bosch

David Berron

Meera Srikrishna

Fiona Heeman

...

2023/12

The association between microstructural MRI biomarkers and sequential amyloid and tau‐related cortical changes in asymptomatic elderly individuals

Alzheimer's & Dementia

Philip SJ Weston

William Coath

Thomas M Brown

Catherine J Scott

Ian B Malone

...

2023/12

REAL AD–A realistic screening approach for preclinical Alzheimer’s disease

Alzheimer's & Dementia

Kaj Blennow

Fiona Heeman

Silke Kern

Alexis Moscoso

Henrik Zetterberg

...

2023/12

The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact

Lyduine E Collij

Gill Farrar

David Valléz García

Ilona Bader

Mahnaz Shekari

...

2023/1/20

APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly

Alzheimer's Research & Therapy

Anniina Snellman

Laura L Ekblad

Jouni Tuisku

Mikko Koivumäki

Nicholas J Ashton

...

2023/4/4

See List of Professors in Michael Schöll, PhD University(Göteborgs universitet)

Co-Authors

H-index: 122
Oskar Hansson

Oskar Hansson

Lunds Universitet

H-index: 89
Niklas Mattsson-Carlgren, MD, PhD

Niklas Mattsson-Carlgren, MD, PhD

Lunds Universitet

H-index: 67
Rik Ossenkoppele

Rik Ossenkoppele

Vrije Universiteit Amsterdam

H-index: 57
Nicholas James Ashton

Nicholas James Ashton

Göteborgs universitet

H-index: 49
Ruben Smith

Ruben Smith

Lunds Universitet

H-index: 32
IL Han Choo, MD, PhD

IL Han Choo, MD, PhD

Chosun University

academic-engine